Deguelin is a derivative of rotenone. Both are compounds classified as rotenoids of the flavonoid family and are naturally occurring insecticides. They can be produced by extraction from several plant species belonging to three genera of the Fabaceae or Legume family, Lonchocarpus, Derris, or Tephrosia. Deguelin displays anti-cancer activity by inhibiting the growth of pre-cancerous and cancerous cells - particularly for lung cancer. So far the compound has shown no toxic effects on normal cells. However, high doses of deguelin are suspected of having negative effects on the heart, lungs and nerves. The molecular mechanisms include the induction of apoptosis, mediatated through AKT/PKB signaling pathways in malignant and premaligant human bronchial epithelia cells, with only minimal effects on normal HBE cells. Deguelin inhibits AKT by both Phosphoinositol-3-phosphate kinase-dependent and PI3K-independent pathways.
Organism species: Pan-species (General)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Complete Antigen of Deguelin (DG) | Antigenic Transformation Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Deguelin (DG) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Deguelin (DG) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Deguelin (DG) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Deguelin (DG) | ELISA Kit Customized Service Offer |